Bioprinting of a Liposomal Oxygen-Releasing Scaffold for Ovary Tissue Engineering
- 1 January 2025
- journal article
- research article
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 31 (1-2) , 69-78
Abstract
This study addresses a critical challenge in bioprinting for regenerative medicine, specifically the issue of hypoxia compromising cell viability in engineered tissues. To overcome this hurdle, a novel approach utilizing a microfluidic bioprinter is employed to create a two-layer structure resembling the human ovary. This structure incorporates a liposomal oxygen-releasing system to enhance cell viability. The bioprinting technique enables the simultaneous extrusion of two distinct bioinks, namely bioink A (comprising alginate 1% and 5mg/ml PEGylated fibrinogen in a 20:1 molar ratio) and bioink B (containing alginate 0.5%). Additionally, liposomal catalase and H2O2 are synthesized and incorporated into bioinks A and B, respectively. The liposomes are prepared using thin film hydration with a monodisperse size (140-160 nm) and high encapsulation efficiency. To assess construct functionality, isolated human ovarian cells are added to bioink A. The bioprinted constructs, with or without liposomal oxygen-releasing systems, are cultured under hypoxic and normoxic conditions for 3 days. Live/Dead assay results demonstrate that liposomal oxygen-releasing systems effectively preserve cell viability in hypoxic conditions, resembling viability under normoxic conditions without liposomes. PrestoBlue assay reveals significantly higher mitochondrial activity in constructs with liposomal oxygen delivery systems under both hypoxic and normoxic conditions. The evaluation of apoptosis status through Annexin V immunostaining shows that liposomal oxygen-releasing scaffolds successfully protect cells from hypoxic stress, exhibiting a proportion of apoptotic cells similar to normoxic conditions. In contrast, constructs lacking liposomes in hypoxic conditions exhibit a higher incidence of cells in early-stage apoptosis. In conclusion, the study demonstrates the promising potential of bioprinted oxygen-releasing liposomal scaffolds to protect ovarian stromal cells in hypoxic environments. These innovative scaffolds not only offer protection but also recapitulate the mechanical differences between the medulla and cortex in the normal ovary structure. This opens new avenues for advanced ovary tissue engineering and transplantation strategies.Keywords
This publication has 67 references indexed in Scilit:
- Extracellular matrix-templating fibrous hydrogels promote ovarian tissue remodeling and oocyte growthBioactive Materials, 2024
- Polyvinylpyrrolidone-based bioink: influence of bioink properties on printing performance and cell proliferation during inkjet-based bioprintingBio-Design and Manufacturing, 2023
- Fabrication of amine‐decorated nonspherical microparticles with calcium peroxide cargo for controlled release of oxygenJournal of Biomedical Materials Research Part A, 2019
- Emerging Biofabrication Strategies for Engineering Complex Tissue ConstructsAdvanced Materials, 2017
- The crucial role of mechanical heterogeneity in regulating follicle development and ovulation with engineered ovarian microtissueBiomaterials, 2014
- Controlled release of oxygen from PLGA-alginate layered matrix and its in vitro characterization on the viability of muscle cells under hypoxic environmentTissue Engineering and Regenerative Medicine, 2013
- Transplantation of an alginate–matrigel matrix containing isolated ovarian cells: First step in developing a biodegradable scaffold to transplant isolated preantral follicles and ovarian cellsBiomaterials, 2012
- An oxygen release system to augment cardiac progenitor cell survival and differentiation under hypoxic conditionBiomaterials, 2012
- Oxygen generating scaffolds for enhancing engineered tissue survivalBiomaterials, 2009
- Annexin V-Affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposureCytometry, 1998